U.S. Gas Utilities Stock News

On 27 June 2026, Rubrik, Inc. (NYSE:RBRK) was removed from the Russell 1000 Value-Defensive, Defensive, and Growth-Defensive indices, a change that can influence how index-tracking funds and benchmarked portfolios treat the stock. These index removals arrive just days after new AI governance collaborations with Amazon Bedrock AgentCore and Cognizant, highlighting a contrast between Rubrik’s product momentum and its shifting role in key equity benchmarks. We’ll now examine how Rubrik’s...

Why a proposed class action settlement matters for Oppenheimer Holdings Oppenheimer Holdings (OPY) is back in focus after Oppenheimer & Co. Inc. agreed to a proposed US$70,000,000 settlement in a class action lawsuit, with court approval scheduled to be considered in September 2026. See our latest analysis for Oppenheimer Holdings. The proposed settlement arrives at a time when Oppenheimer Holdings has seen a 30-day share price return of 15.13% and a year-to-date share price return of 45.29%...

BridgeBio Pharma has released previously announced positive Phase 3 PROPEL 3 data for oral infigratinib in children with achondroplasia, now published in the New England Journal of Medicine, showing statistically significant gains in annualized height velocity, body proportionality and arm span with a favorable safety profile. The company now plans to file regulatory applications in the US and EU starting in the third quarter of 2026, positioning oral infigratinib as a potential first...

Hinge Health (NYSE:HNGE) has been added to multiple major Russell indexes following its latest quarterly results. The index changes coincide with the company reporting strong quarterly performance. Hinge Health also raised its full year guidance around the same time as the Russell index inclusions. The combination of broader index exposure and updated outlook marks a key moment for the company’s public market profile. Hinge Health focuses on digital musculoskeletal care, an area that sits...

Index reshuffle puts fresh attention on nCino stock nCino (NCNO) is back in focus after a broad reshuffle of its index memberships, with the stock added to several Russell 2000 segments while being removed from multiple Russell 1000 and Midcap benchmarks. These shifts typically prompt passive index trackers to rebalance their holdings, which can influence trading volumes around the effective date and encourage active investors to reassess how nCino fits within small cap, growth, and value...

Index removals put Plexus stock in focus Plexus (PLXS) has been removed from several Russell value indices, including the Russell 2000 Value and Russell 3000 Value. This index reshuffle can influence trading as passive funds adjust positions. See our latest analysis for Plexus. The index removals come at a time when Plexus has seen strong momentum, with a 90 day share price return of 45.10% and a year to date share price return of 97.51%, while the 1 year total shareholder return sits at...

LPL Financial Holdings (LPLA) has just been added to several Russell value benchmarks, including the Russell 1000 Value and Russell 3000 Value indices. This shift can influence index-driven demand and attention. See our latest analysis for LPL Financial Holdings. The Russell index additions come after a mixed stretch for LPL Financial Holdings, with the share price rising 4.62% in the last day and 2.89% over 30 days, but declining 22.11% year to date. The 5 year total shareholder return sits...

In late June 2026, Apollo Commercial Real Estate Finance, Inc. (NYSE: ARI) was removed from multiple major equity indices, including the S&P Composite 1500, S&P SmallCap 600, S&P 1000 and several Russell growth and small‑cap benchmarks, following index reconstitutions. This broad index exclusion reduces automatic ownership by index‑tracking funds and could influence liquidity, trading patterns and how investors assess ARI within the listed mortgage REIT universe. We’ll now examine how ARI’s...

Why Semtech’s latest quarter matters for investors Semtech (SMTC) has just reported first quarter fiscal 2027 results that topped earnings expectations while guiding second quarter net sales higher, prompting analysts to revisit their assumptions about the company’s operating momentum and business outlook. For investors, this combination of an earnings beat and raised sales guidance typically shifts attention from short term trading moves toward how sustainably the underlying business is...

AI infrastructure has shifted from a niche theme to a major force in markets, as investors respond to headlines about Micron, Intel, AMD and other chip stocks adding trillions in combined market value. Instead of chasing every hype cycle, it can help to focus on companies with solid financial and market metrics that are directly exposed to this AI infrastructure build out. This article walks through 3 stocks from our AI Infrastructure Beneficiaries screener that appear positively exposed to...

Urban Outfitters (URBN) has been removed from the Russell 2000 Dynamic Index, a shift that can influence how index-tracking funds treat the stock and potentially affect short term trading flows. See our latest analysis for Urban Outfitters. At a share price of US$70.86, Urban Outfitters has seen short term share price pressure, with the 30 day share price return down 2.46%, while the 90 day share price return is up 11.21% and the 3 year total shareholder return is 110.14%. This points to...

Matson (MATX) has been drawing investor attention after a strong share price move, with the stock up about 6% over the past month and about 16% in the past 3 months. See our latest analysis for Matson. At around $192 per share, Matson’s recent 6% 1 month share price return and 16.6% 3 month share price return sit on top of a much stronger backdrop, with a 55.4% year to date share price return and 69.8% 1 year total shareholder return pointing to momentum that has been building rather than...

Interest rate headlines are back in focus as the Federal Reserve signals a possible pause or slowdown in hikes, and that matters for rate sensitive areas like Real Estate and Utilities. With mixed economic data and a cautious central bank, some stocks in these sectors may see sentiment shift as investors rethink income, value, and balance sheet risk. This article looks at 3 stocks from a Rate Sensitive Sectors screener that appear positively exposed to the current Fed stance. It is intended...

Following a 23% one day jump after its latest earnings release, Twilio (TWLO) has seen its share price cool, creating fresh interest among investors who are assessing whether this reset offers a more measured entry. See our latest analysis for Twilio. That sharp earnings gap and subsequent cool off sit within a wider upswing for Twilio, with a 90 day share price return of 58.16% and a 1 year total shareholder return of 76.00%. This indicates momentum that has recently been strong rather than...

In late June 2026, CareTrust REIT, Inc. (NYSE: CTRE) was removed from multiple Russell growth and small-cap indexes, shortly after its Board reaffirmed a quarterly cash dividend of US$0.39 per share payable in mid-July to shareholders of record on June 30, 2026. This combination of index deletions and steady dividend payments highlights a tension between potential index-related selling pressure and the company’s ongoing income profile for shareholders. Against this backdrop, we will examine...

In late June 2026, Loar Holdings Inc. (NYSE: LOAR) was removed from several Russell growth indices, including the Russell 1000 Growth, Russell 3000 Growth, Russell 3000E Growth, Russell Midcap Growth, and Russell 2500 Growth benchmarks, prompting benchmark-driven portfolio rebalancing. This broad index removal contrasts with ongoing positive analyst views and hedge fund interest, highlighting how benchmark membership can materially influence investor demand and company visibility. Next,...

Cytokinetics reported progress in turning its lead heart drug Myqorzo from a development program into an early commercial product, supported by prior regulatory approvals in the US, Europe, and China. Early physician adoption and patient response, together with Myqorzo’s differentiated mechanism in obstructive hypertrophic cardiomyopathy, are sharpening expectations around its broader clinical and competitive role. Next, we’ll look at how Myqorzo’s early commercial uptake and multi-region...

Whirlpool stock performance snapshot Whirlpool (WHR) stock has been under pressure recently, with the share price around $39.42 and total returns declining over the past month, past 3 months, year to date, and the past 1 year. See our latest analysis for Whirlpool. For Whirlpool, the recent 1 week share price return of 8.93% comes after a tougher stretch, with the 30 day share price return down 9.21% and the 1 year total shareholder return down 61.20%. This suggests recent momentum is...

Viridian Therapeutics (VRDN) is in focus after the U.S. Food and Drug Administration approved Lumvoa for thyroid eye disease, covering both active and chronic forms. The stock moved 6% higher after hours. See our latest analysis for Viridian Therapeutics. Viridian Therapeutics’ latest FDA approval comes after a mixed stretch for holders, with the share price down 40.11% year to date but a 1 year total shareholder return of 26.99%. This suggests sentiment has shifted recently as new catalysts...

Drone defense sits at the crossroads of national security, energy driven inflation stories, and shifting government budgets, yet not every stock in this area is built to handle long procurement cycles or rising funding costs. With inflation trends diverging across regions and bond yields and currencies moving on central bank signals, many investors are focusing on companies with strong balance sheets and solid cash cushions. This Financially Strong Drone Defense Stocks screener filters for...

In late June 2026, Arcutis Biotherapeutics announced FDA approval to extend ZORYVE cream 0.3% plaque psoriasis treatment to children aged 2–5, alongside launching a virtual health platform that connects eczema, seborrheic dermatitis, and plaque psoriasis patients with independent dermatologists for streamlined access to care. This combination of a broader pediatric indication and a company-backed but physician-directed digital access channel could meaningfully influence how ZORYVE reaches...

Aon (AON) has come under focus after being removed from several Russell growth indices. This shift can influence passive fund flows, investor perception, and how growth-focused portfolios treat the stock. See our latest analysis for Aon. Following the Russell growth index removals, Aon’s recent momentum has been mixed, with a 7 day share price return of 3.41% and a year to date share price return that is down 3.65%, alongside a 5 year total shareholder return of 45.21%. If you are reassessing...

Associated Banc-Corp recently announced that Andy Miner has joined as senior director, AI for Corporate & Commercial Banking, where he will lead AI strategy, use cases, delivery, adoption, and oversight of risk and data for the business. By appointing a dedicated AI leader with experience scaling analytics teams at U.S. Bank and Target, Associated is signaling a deeper push to embed data-driven decision-making into its commercial banking operations. Next, we’ll examine how Miner's...

On 27 June 2026, NPK International Inc. (NYSE:NPKI) was reclassified across the Russell index family, joining several growth-focused benchmarks while exiting a range of value-oriented indexes, including the Russell 2000 Value and Russell 3000 Value benchmarks. This broad shift from value to growth classifications signals that index providers now see NPK International’s profile as more aligned with growth characteristics, which can influence how both passive and active investors categorize...